Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Net Cash Flow: 2020-2025

Historic Net Cash Flow for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to $2.2 million.

  • iSpecimen's Net Cash Flow rose 649.33% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 206.47%. This contributed to the annual value of -$465,258 for FY2024, which is 96.41% up from last year.
  • Latest data reveals that iSpecimen reported Net Cash Flow of $2.2 million as of Q3 2025, which was up 1,241.31% from -$192,234 recorded in Q2 2025.
  • Over the past 5 years, iSpecimen's Net Cash Flow peaked at $17.9 million during Q4 2021, and registered a low of -$11.5 million during Q1 2023.
  • In the last 3 years, iSpecimen's Net Cash Flow had a median value of -$253,775 in 2024 and averaged -$1.1 million.
  • The largest annual percentage gain for iSpecimen's Net Cash Flow in the last 5 years was 6,967.86% (2021), contrasted with its biggest fall of 888.48% (2021).
  • Over the past 5 years, iSpecimen's Net Cash Flow (Quarterly) stood at $17.9 million in 2021, then slumped by 129.80% to -$5.3 million in 2022, then skyrocketed by 92.94% to -$377,902 in 2023, then surged by 133.49% to $126,554 in 2024, then spiked by 649.33% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, -$192,234 for Q2 2025, and -$1.1 million during Q1 2025.